IM Cannabis Corp. (IMCC) stock

IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026Score 4/30

$0.55−0.02 (-3.83%)

Close on Nov 12, 2026Market cap $3.26MP/E –Yield –

IM Cannabis ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2022 it was -C$27.98M.

Period	Period end	Value	Change
FY2022	Dec 31, 2022	-C$27.98M	–
FY2021	Dec 31, 2021	-C$20.91M	–
FY2020	Dec 31, 2020	-C$7.32M	–
FY2019	Dec 31, 2019	-C$9.67M	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2024	Jun 30, 2024	-C$2.36M	–
Q2 FY2023	Jun 30, 2023	-C$974.00K	–
Q2 FY2022	Jun 30, 2022	-C$4.78M	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IMCC.

Revenue growth1.3% · median 33.2%

Gross margin17.7% · median 35.5%

Operating margin-21.2% · median -25.4%

Net margin-20.7% · median -29.5%

Advertisement
300 × 250

See a number that looks wrong?